Park Ha Biological Technology Co., Ltd. Ordinary Shares BYAH

Park Ha Biological Technology Co Ltd is engaged in developing its private skincare label, direct skincare products sales, and franchise alliances promotions. Its Park Ha brand focuses on providing solutions for problematic skin. The company's Operating Subsidiaries provide skincare and cosmetic products under its brand, Park Ha, in China. Its Operating Subsidiaries develop its proprietary beauty products and offer complementary after-sales beauty services in its physical stores.

BYAH hizo una agrupación de acciones (split inverso) de 1:8 el 6 de agosto de 2026: cada 8 acciones se juntaron en una. Bajó la cantidad de acciones y subió su precio, pero no el valor total de la inversión.

• GlobeNewswire Inc. 24 sept

  Bronstein, Gewirtz & Grossman LLC Urges Park Ha Biological Technology Co., Ltd. Investors to Act: Class Action Filed Alleging Investor Harm

  A class action lawsuit has been filed against Park Ha Biological Technology Co., Ltd. (NASDAQ: BYAH) alleging securities fraud. The complaint claims the company made false and misleading statements, failed to disclose a fraudulent stock promotion and market manipulation scheme involving social media misinformation, and intentionally structured its IPO with an extremely low public float to facilitate manipulation. Investors who purchased Park Ha securities between December 27, 2024 and July 8, 2025 are encouraged to join the case, with a lead plaintiff deadline of September 28, 2026.

  

• GlobeNewswire Inc. 23 sept

  PHH, BYAH DEADLINE: ROSEN, NATIONAL INVESTOR COUNSEL, Encourages Park Ha Biological Technology Co., Ltd. Investors to Secure Counsel Before Important September 28 Deadline in Securities Class Action - PHH, BYAH

  A securities class action lawsuit has been filed against Park Ha Biological Technology Co., Ltd. for allegedly making materially false statements and failing to disclose a fraudulent stock promotion scheme involving social media misinformation and artificially manipulated trading activity. Investors who purchased securities between December 27, 2024 and July 8, 2025 are encouraged to seek legal counsel before the September 28, 2026 lead plaintiff deadline.

  

• GlobeNewswire Inc. 20 sept

  PHH, BYAH FINAL DEADLINE: ROSEN, LEADING TRIAL ATTORNEYS, Encourages Park Ha Biological Technology Co., Ltd. Investors to Secure Counsel Before Important September 28 Deadline in Securities Class Action - PHH, BYAH

  Rosen Law Firm announces a securities class action lawsuit against Park Ha Biological Technology Co., Ltd. (NASDAQ: PHH, BYAH) for investors who purchased securities between December 27, 2024 and July 8, 2025. The lawsuit alleges that defendants made materially false statements and failed to disclose a fraudulent stock promotion scheme involving social media misinformation, impersonated financial professionals, and artificially manipulated trading activity. The lead plaintiff deadline is September 28, 2026.

  

• GlobeNewswire Inc. 12 sept

  ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Lincoln Educational Services Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action - LINC

  Rosen Law Firm has filed class action lawsuits against Lincoln Educational Services Corporation and other companies on behalf of investors who purchased securities during specified periods. The lawsuit alleges that Lincoln Educational Services made false statements about its admissions process and student conversion rates, resulting in misleading statements about business operations and prospects. Investors who purchased securities during the class period may be entitled to compensation.

  

• GlobeNewswire Inc. 6 sept

  CAR DEADLINE NOTICE: ROSEN, A GLOBALLY RECOGNIZED LAW FIRM, Encourages Avis Budget Group, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action Against Pentwater Capital Management LP - CAR

  Rosen Law Firm is notifying investors in Avis Budget Group (CAR) and Park Ha Biological Technology (PHH, BYAH) about ongoing securities class action lawsuits. The Avis lawsuit alleges that Pentwater Capital Management LP and its CEO orchestrated a market manipulation scheme involving aggressive stock purchases that triggered a short squeeze, artificially inflating stock prices. Investors with losses exceeding $100,000 are encouraged to join the class action before the September 29, 2026 deadline.